BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27255356)

  • 1. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.
    Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A
    BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.
    Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J
    Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].
    Vukoja V; Brandenbusch T; Tura A; Nassar K; Rohrbach DJ; Lüke M; Grisanti S; Lüke J
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):290-7. PubMed ID: 26854480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
    Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
    Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
    El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
    J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
    Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
    Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
    Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
    Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
    Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
    Huang L; Xu AM; Peng Q
    Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
    Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG
    Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
    Woodward JK; Rennie IG; Burn JL; Sisley K
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
    Alyahya GA
    Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
    Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
    Greco IM; Calvisi G; Ventura L; Cerrito F
    Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
    Voigt H; Houben R; Schrama D; Hofmann UB; Vetter-Kauczok CS; Becker JC
    Tumour Biol; 2007; 28(4):229-37. PubMed ID: 17709990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.